High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells

DNA Repair

Volumn 36, Issue , 2015, Pages 122-136

  Reeves, Raymond ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Base excision repair (BER); Chromatin remodeling; Double strand break repair (DSBR); HMGA; HMGB; HMGN; Mismatch repair (MMR); Nucleotide excision repair (NER)

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP B PROTEIN; HIGH MOBILITY GROUP N PROTEIN; HIGH MOBILITY GROUP PROTEIN; HISTONE H1; HISTONE H3; MITOCHONDRIAL DNA; PROTEIN P53; XERODERMA PIGMENTOSUM GROUP A PROTEIN; CHROMATIN; DNA;

CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DNA END JOINING REPAIR; DNA REPAIR; DNA STRUCTURE; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HUMAN; MAMMAL CELL; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; VDJ RECOMBINATION; ANIMAL; CHEMISTRY; CHROMATIN; GENETICS; MAMMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA; DNA REPAIR; HIGH MOBILITY GROUP PROTEINS; HUMANS; MAMMALS;

EID: 84961972153     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2015.09.015     Document Type: Review

References (239)

1. Smerdon M.J., Lieberman M.W. Nucleosome rearrangement in human chromatin during UV-induced DNA-reapir synthesis. Proc. Natl. Acad. Sci. U. S. A. 1978, 75(9):4238-4241.
2. Smerdon M.J. DNA repair and the role of chromatin structure. Curr. Opin. Cell Biol. 1991, 3(3):422-428.
3. Czaja W., Mao P., Smerdon M.J. The emerging roles of ATP-dependent chromatin remodeling enzymes in nucleotide excision repair. Int. J. Mol. Sci. 2012, 13(9):11954-11973.
4. Jeggo P.A., Downs J.A. Roles of chromatin remodellers in DNA double strand break repair. Exp. Cell Res. 2014, 329(1):69-77.
5. Swygert S.G., Peterson C.L. Chromatin dynamics: interplay between remodeling enzymes and histone modifications. Biochim. Biophys. Acta 2014, 1839(8):728-736.
6. Polo S.E. Reshaping chromatin after DNA damage: the choreography of histone proteins. J. Mol. Biol. 2015, 427(3):626-636.
7. Bustin M., Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 1996, 54:35-100.
8. Bustin M. Revised nomenclature for high mobility group chromosomal proteins. Trends Biochem. Sci. 2001, 26:151-153.
9. Reeves R. Nuclear functions of the HMG proteins. Biochim. Biophys. Acta 2010, 1799(1-2):3-14.
10. Catez F., Hock R. Binding and interplay of HMG proteins on chromatin: lessons from live cell imaging. Biochim. Biophys. Acta 2010, 1799(1-2):15-27.
11. Zhang Q., Wang Y. HMG modifications and nuclear function. Biochim. Biophys. Acta 2010, 1799(1-2):28-36.
12. Sgarra R., et al. HMGA molecular network: from transcriptional regulation to chromatin remodeling. Biochim. Biophys. Acta 2010, 1799(1-2):37-47.
13. Resar L.M. The high mobility group A1 gene: transforming inflammatory signals into cancer?. Cancer Res. 2010, 70(2):436-439.
14. Ozturk N., et al. HMGA proteins as modulators of chromatin structure during transcriptional activation. Front. Cell Dev. Biol. 2014, 2:p. 5.
15. Ashar H.R., et al. In vivo modulation of HMGA2 expression. Biochim. Biophys. Acta 2010, 1799(1-2):55-61.
16. Ueda T., Yoshida M. HMGB proteins and transcriptional regulation. Biochim. Biophys. Acta 2010, 1799(1-2):114-118.
17. Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim. Biophys. Acta 2010, 1799(1-2):101-113.
18. Tang D., et al. High-mobility group box 1 and cancer. Biochim. Biophys. Acta 2010, 1799(1-2):131-140.
19. Vande Walle L., Kanneganti T.D., Lamkanfi M. HMGB1 release by inflammasomes. Virulence 2011, 2(2):162-165.
20. Thomas J.O., Stott K. H1 and HMGB1: modulators of chromatin structure. Biochem. Soc. Trans. 2012, 40(2):341-346.
21. Postnikov Y., Bustin M. Regulation of chromatin structure and function by HMGN proteins. Biochim. Biophys. Acta 2010, 1799(1-2):62-68.
22. Zhu N., Hansen U. Transcriptional regulation by HMGN proteins. Biochim. Biophys. Acta 2010, 1799(1-2):74-79.
23. Furusawa T., Cherukuri S. Developmental function of HMGN proteins. Biochim. Biophys. Acta 2010, 1799(1-2):69-73.
24. Reeves R., Adair J.E. Role of high mobility group (HMG) chromatin proteins in DNA repair. DNA Repair (Amst.) 2005, 4(8):926-938.
25. West K.L. HMGN proteins play roles in DNA repair and gene expression in mammalian cells. Biochem. Soc. Trans. 2004, 32(Pt 6):918-919.
26. Pogna E.A., Clayton A.L., Mahadevan L.C. Signalling to chromatin through post-translational modifications of HMGN. Biochim. Biophys. Acta 2010, 1799(1-2):93-100.
27. Gerlitz G. HMGNs, DNA repair and cancer. Biochim. Biophys. Acta 2010, 1799(1-2):80-85.
28. Rochman M., Malicet C., Bustin M. HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function. Biochim. Biophys. Acta 2010, 1799(1-2):86-92.
29. Gonzalez-Romero R., Eirin-Lopez J.M., Ausio J. Evolution of high mobility group nucleosome-binding proteins and its implications for vertebrate chromatin specialization. Mol. Biol. Evol. 2015, 32(1):121-131.
30. Ueda T., et al. Delineation of the protein module that anchors HMGN proteins to nucleosomes in the chromatin of living cells. Mol. Cell Biol. 2008, 28(9):2872-2883.
31. Bustin M. Chromatin unfolding and activation by HMGN(*) chromosomal proteins. Trends Biochem. Sci. 2001, 26(7):431-437.
32. Ding H.F., Bustin M., Hansen U. Alleviation of histone H1-mediated transcriptional repression and chromatin compaction by the acidic activation region in chromosomal protein HMG-14. Mol. Cell Biol. 1997, 17(10):5843-5855.
33. Ueda T., Postnikov Y.V., Bustin M. Distinct domains in high mobility group N variants modulate specific chromatin modifications. J. Biol. Chem. 2006, 281(15):10182-10187.
34. Phair R.D., Misteli T. High mobility of proteins in the mammalian cell nucleus. Nature 2000, 404(6778):604-609.
35. Phair R.D., et al. Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol. Cell Biol. 2004, 24(14):6393-6402.
36. Catez F., et al. Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol. Cell Biol. 2004, 24(10):4321-4328.
37. Catez F., et al. Competition between histone H1 and HMGN proteins for chromatin binding sites. EMBO Rep. 2002, 3(8):760-766.
38. Subramanian M., et al. The nucleosome-binding protein HMGN2 modulates global genome repair. FEBS J. 2009, 276(22):6646-6657.
39. Lim J.H., et al. Chromosomal protein HMGN1 enhances the acetylation of lysine 14 in histone H3. EMBO J. 2005, 24(17):3038-3048.
40. Postnikov Y.V., et al. Chromosomal protein HMGN1 modulates the phosphorylation of serine 1 in histone H2A. Biochemistry 2006, 45(50):15092-15099.
41. Rattner B.P., Yusufzai T., Kadonaga J.T. HMGN proteins act in opposition to ATP-dependent chromatin remodeling factors to restrict nucleosome mobility. Mol. Cell 2009, 34(5):620-626.
42. Birger Y., et al. Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1. Cancer Res. 2005, 65(15):6711-6718.
43. Birger Y., et al. Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin. EMBO J. 2003, 22(7):1665-1675.
44. Thompson L.H., et al. A screening method for isolating DNA repair-deficient mutants of CHO cells. Somatic Cell Genet. 1980, 6(3):391-405.
45. Wood R.D., Mitchell M., Lindahl T. Human DNA repair genes. Mutat. Res. 2005, 577(1-2):275-283.
46. Fousteri M., Mullenders L.H. Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 2008, 18(1):73-84.
47. Hanawalt P.C., Spivak G. Transcription-coupled DNA repair: two decades of progress and surprises. Nat. Rev. Mol. Cell Biol. 2008, 9(12):958-970.
48. Lagerwerf S., et al. DNA damage response and transcription. DNA Repair (Amst.) 2011, 10(7):743-750.
49. Shuck S.C., Short E.A., Turchi J.J. Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Res. 2008, 18(1):64-72.
50. Stevnsner T., et al. The role of Cockayne Syndrome group B (CSB) protein in base excision repair and aging. Mech. Ageing Dev. 2008, 129(7-8):441-448.
51. Donahue B.A., et al. Transcript cleavage by RNA polymerase II arrested by a cyclobutane pyrimidine dimer in the DNA template. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(18):8502-8506.
52. Tornaletti S., Hanawalt P.C. Effect of DNA lesions on transcription elongation. Biochimie 1999, 81(1-2):139-146.
53. Fousteri M., et al. Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol. Cell 2006, 23(4):471-482.
54. Hill D.A., Peterson C.L., Imbalzano A.N. Effects of HMGN1 on chromatin structure and SWI/SNF-mediated chromatin remodeling. J. Biol. Chem. 2005, 280(50):41777-41783.
55. Weterings E., Chen D.J. The endless tale of non-homologous end-joining. Cell Res. 2008, 18(1):114-124.
56. Lee J.H., Paull T.T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 2005, 308(5721):551-554.
57. Lee J.H., Paull T.T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 2004, 304(5667):93-96.
58. Paull T.T., Lee J.H. The Mre11/Rad50/Nbs1 complex and its role as a DNA double-strand break sensor for ATM. Cell Cycle 2005, 4(6):737-740.
59. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 2006, 31(7):402-410.
60. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9(10):759-769.
61. Ward I., Chen J. Early events in the DNA damage response. Curr. Top. Dev. Biol. 2004, 63:1-35.
62. Harper J.W., Elledge S.J. The DNA damage response: ten years after. Mol. Cell 2007, 28(5):739-745.
63. Kruhlak M.J., et al. Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks. J. Cell Biol. 2006, 172(6):823-834.
64. Park J.H., et al. Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. EMBO J. 2006, 25(17):3986-3997.
65. Falk M., et al. Chromatin dynamics during DSB repair. Biochim. Biophys. Acta 2007, 1773(10):1534-1545.
66. Huen M.S., et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 2007, 131(5):901-914.
67. Mailand N., et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 2007, 131(5):887-900.
68. Das C., et al. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 2009, 459(7243):113-117.
69. Ziv Y., et al. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat. Cell Biol. 2006, 8(8):870-876.
70. Downs J.A., Nussenzweig M.C., Nussenzweig A. Chromatin dynamics and the preservation of genetic information. Nature 2007, 447(7147):951-958.
71. Kim Y.C., et al. Activation of ATM depends on chromatin interactions occurring before induction of DNA damage. Nat. Cell Biol. 2009, 11(1):92-96.
72. Baute J., Depicker A. Base excision repair and its role in maintaining genome stability. Crit. Rev. Biochem. Mol. Biol. 2008, 43(4):239-276.
73. Wilson S.H., et al. Base excision repair and design of small molecule inhibitors of human DNA polymerase beta. Cell Mol. Life Sci. 2010, 67(21):3633-3647.
74. Asagoshi K., et al. Single-nucleotide base excision repair DNA polymerase activity in C. elegans in the absence of DNA polymerase beta. Nucleic Acids Res. 2012, 40(2):670-681.
75. Dantzer F., et al. Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1. Biochemistry 2000, 39(25):7559-7569.
76. Sukhanova M.V., et al. Human base excision repair enzymes apurinic/apyrimidinic endonuclease1 (APE1), DNA polymerase beta and poly(ADP-ribose) polymerase 1: interplay between strand-displacement DNA synthesis and proofreading exonuclease activity. Nucleic Acids Res. 2005, 33(4):1222-1229.
77. Masaoka A., et al. DNA polymerase beta and PARP activities in base excision repair in living cells. DNA Repair (Amst.) 2009, 8(11):1290-1299.
78. Caldecott K.W., et al. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res. 1996, 24(22):4387-4394.
79. Nash R.A., et al. XRCC1 protein interacts with one of two distinct forms of DNA ligase III. Biochemistry 1997, 36(17):5207-5211.
80. Hong S.J., Dawson T.M., Dawson V.L. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol. Sci. 2004, 25(5):259-264.
81. D'Amours D., et al. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 1999, 342(Pt 2):249-268.
82. Krishnakumar R., Kraus W.L. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol. Cell 2010, 39(1):8-24.
83. Masaoka A., et al. HMGN1 protein regulates poly(ADP-ribose) polymerase-1 (PARP-1) self-PARylation in mouse fibroblasts. J. Biol. Chem. 2012, 287(33):27648-27658.
84. Reeves R., Nissen M.S. The A. T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J. Biol. Chem. 1990, 265(15):8573-8582.
85. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 2001, 277(1-2):63-81.
86. Johnson K.R., Lehn D.A., Reeves R. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol. Cell Biol. 1989, 9(5):2114-2123.
87. Friedmann M., et al. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res. 1993, 21(18):4259-4267.
88. Ashar H.R., et al. Genomic characterization of human HMGIC, a member of the accessory transcription factor family found at translocation breakpoints in lipomas. Genomics 1996, 31(2):207-214.
89. Hauke S., et al. Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene. Biochim. Biophys. Acta 2005, 1729(1):24-31.
90. Reeves R., Beckerbauer L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta 2001, 1519(1-2):13-29.
91. Reeves R. HMGA proteins: flexibility finds a nuclear niche?. Biochem. Cell Biol. 2003, 81(3):185-195.
92. Zhou X., Chada K. HMGI family proteins: architectural transcription factors in mammalian development and cancer. Keio J. Med. 1998, 47(2):73-77.
93. Hammond S.M., Sharpless N.E. HMGA2, microRNAs, and stem cell aging. Cell 2008, 135(6):1013-1016.
94. Chandra T., Narita M. High-order chromatin structure and the epigenome in SAHFs. Nucleus 2013, 4(1):23-28.
95. Narita M., et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006, 126(3):503-514.
96. Young A.R., Narita M. Oncogenic HMGA2: short or small?. Genes Dev. 2007, 21(9):1005-1009.
97. Fedele M., Fusco A. HMGA and cancer. Biochim. Biophys. Acta 2010, 1799(1-2):48-54.
98. Semple R.K. From bending DNA to diabetes: the curious case of HMGA1. J. Biol. 2009, 8(7):64.
99. Brunetti A., Chiefari E., Foti D. Recent advances in the molecular genetics of type 2 diabetes mellitus. World J. Diabetes 2014, 5(2):128-140.
100. Pullinger C.R., et al. Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population. Metab. Syndr. Relat. Disord. 2014, 12(1):25-30.
101. Anand A., Chada K. In vivo modulation of Hmgic reduces obesity. Nat. Genet. 2000, 24(4):377-380.
102. Thies H.W., et al. Permanent activation of HMGA2 in lipomas mimics its temporal physiological activation linked to the gain of adipose tissue. Obesity (Silver Spring) 2014, 22(1):141-150.
103. Manabe T., et al. HMGA1a: sequence-specific RNA-binding factor causing sporadic Alzheimer's disease-linked exon skipping of presenilin-2 pre-mRNA. Genes Cells 2007, 12(10):1179-1191.
104. Manabe T., et al. Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease. Cell Death Differ. 2003, 10(6):698-708.
105. Morikawa T., et al. The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients. Neurochem. Int. 2010, 56(6-7):736-739.
106. Ohe K., Mayeda A. HMGA1a trapping of U1 snRNP at an authentic 5' splice site induces aberrant exon skipping in sporadic Alzheimer's disease. Mol. Cell Biol. 2010, 30(9):2220-2228.
107. Thanos D., Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 1995, 83(7):1091-1100.
108. Nissen M.S., Reeves R. Changes in superhelicity are introduced into closed circular DNA by binding of high mobility group protein I/Y. J. Biol. Chem. 1995, 270(9):4355-4360.
109. Falvo J.V., Thanos D., Maniatis T. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 1995, 83(7):1101-1111.
110. Chase M.B., et al. Binding of HMG-I(Y) elicits structural changes in a silencer of the human beta-globin gene. Am. J. Hematol. 1999, 60(1):27-35.
111. Chen B., Young J., Leng F. DNA bending by the mammalian high-mobility group protein AT hook 2. Biochemistry 2010, 49(8):1590-1595.
112. Cleynen I., Van de Ven W.J. The HMGA proteins: a myriad of functions (Review). Int. J. Oncol. 2008, 32(2):289-305.
113. Federico A., et al. Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype. Biol. Open 2014, 3(5):372-378.
114. Fedele M., et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res. 2006, 66(5):2536-2543.
115. Chiefari E., et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 2011, 305(9):903-912.
116. Foti D., et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat. Med. 2005, 11(7):765-773.
117. Chieffi P., et al. HMGA1 and HMGA2 protein expression in mouse spermatogenesis. Oncogene 2002, 21(22):3644-3650.
118. Lehn D.A., et al. A conformational study of the sequence specific binding of HMG-I (Y) with the bovine interleukin-2 cDNA. Biochem. Int. 1988, 16(5):963-971.
119. Huth J.R., et al. The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat. Struct. Biol. 1997, 4(8):657-665.
120. Dunker A.K., et al. Intrinsically disordered protein, J. Mol. J. Mol. Graph. Model. 2001, 19(1):26-59.
121. Galande S. Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer. Curr. Cancer Drug Targets 2002, 2(2):157-190.
122. Pruss D., et al. The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J. Biol. Chem. 1994, 269(40):25031-25041.
123. Reeves R., Wolffe A.P. Substrate structure influences binding of the non-histone protein HMG-I(Y) to free nucleosomal DNA. Biochemistry 1996, 35(15):5063-5074.
124. Adair J.E., et al. Inhibition of nucleotide excision repair by high mobility group protein HMGA1. J. Biol. Chem. 2005, 280(37):32184-32192.
125. Hill D.A., Reeves R. Competition between HMG-I(Y), HMG-1 and histone H1 on four-way junction DNA. Nucleic Acids Res. 1997, 25(17):3523-3531.
126. Hill D.A., Pedulla M.L., Reeves R. Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1. Nucleic Acids Res. 1999, 27(10):2135-2144.
127. Subramanian D., Griffith J.D. Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases. Nucleic Acids Res. 2002, 30(11):2427-2434.
128. Reeves R., Langan T.A., Nissen M.S. Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(5):1671-1675.
129. Nissen M.S., Langan T.A., Reeves R. Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J. Biol. Chem. 1991, 266(30):19945-19952.
130. Munshi N., et al. Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 2001, 293(5532):1133-1136.
131. Munshi N., et al. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell 1998, 2(4):457-467.
132. Edberg D.D., et al. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. J. Biol. Chem. 2005, 280(10):8961-8973.
133. Edberg D.D., et al. In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential. Biochemistry 2004, 43(36):11500-11515.
134. Miranda T.B., et al. Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. Biochem. Biophys. Res. Commun. 2005, 336(3):831-835.
135. Zhang Q., Wang Y. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity. J. Proteome Res. 2007, 6(12):4711-4719.
136. Zhang Q., et al. A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins. J. Am. Soc. Mass Spectrom. 2007, 18(9):1569-1578.
137. Zou Y., Wang Y. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues. J. Proteome Res. 2007, 6(6):2304-2314.
138. Zou Y., et al. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation. Biochemistry 2007, 46(26):7896-7906.
139. Gardner K.E., Allis C.D., Strahl B.D. Operating on chromatin, a colorful language where context matters. J. Mol. Biol. 2011, 409(1):36-46.
140. Reeves R., Edberg D.D., Li Y. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell Biol. 2001, 21(2):575-594.
141. Treff N.R., et al. High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells. Oncogene 2004, 23(3):777-785.
142. Maloney S.C., et al. Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteins. DNA Repair (Amst.) 2007, 6(9):1371-1379.
143. Adair J.E., et al. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A. Cancer Res. 2007, 67(13):6044-6052.
144. Borrmann L., et al. High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucleic Acids Res. 2003, 31(23):6841-6851.
145. Westerveld A., et al. Molecular cloning of a human DNA repair gene. Nature 1984, 310(5976):425-429.
146. D'Angelo D., et al. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs. BMC Cancer 2014, 14:851.
147. Dement G.A., Maloney S.C., Reeves R. Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function. Exp. Cell Res. 2007, 313(1):77-87.
148. Dement G.A., et al. Dynamic mitochondrial localization of nuclear transcription factor HMGA1. Exp. Cell Res. 2005, 307(2):388-401.
149. Mao L., et al. HMGA1 levels influence mitochondrial function and mitochondrial DNA repair efficiency. Mol. Cell Biol. 2009, 29(20):5426-5440.
150. Clayton D.A., Doda J.N., Friedberg E.C. The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc. Natl. Acad. Sci. U. S. A. 1974, 71(7):2777-2781.
151. LeDoux S.P., Wilson G.L. Base excision repair of mitochondrial DNA damage in mammalian cells. Prog. Nucleic Acid Res. Mol. Biol. 2001, 68:273-284.
152. Simsek D., et al. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature 2011, 471(7337):245-248.
153. Summer H., et al. HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy. Nucleic Acids Res. 2009, 37(13):4371-4384.
154. Baldassarre G., et al. Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol. Cell Biol. 2003, 23(7):2225-2238.
155. Palmieri D., et al. HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents. Oncogene 2011, 30(27):3024-3035.
156. Pentimalli F., et al. HMGA1 protein is a novel target of the ATM kinase. Eur. J. Cancer 2008, 44(17):2668-2679.
157. Li A.Y., et al. Suppression of nonhomologous end joining repair by overexpression of HMGA2. Cancer Res. 2009, 69(14):5699-5706.
158. Bullerdiek J., Rommel B. Comment re: HMGA2 is a negative regulator of DNA-PK pathway. Cancer Res. 2010, 70(4):1742. author reply 1742.
159. Yamashita N., et al. Terminal deoxynucleotidyltransferase directly interacts with a novel nuclear protein that is homologous to p65. Genes Cells 2001, 6(7):641-652.
160. Battista S., et al. Loss of Hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation. FASEB J. 2003, 17(11):1496-1498.
161. Battista S., et al. High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). Biochem. J. 2005, 389(Pt 1):91-97.
162. Swanson P.C. The bounty of RAGs: recombination signal complexes and reaction outcomes. Immunol. Rev. 2004, 200:90-114.
163. Tallini G., Dal Cin P. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. Adv. Anat. Pathol. 1999, 6(5):237-246.
164. Beckerbauer L., et al. FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo. Chem. Biol. 2000, 7(10):805-812.
165. Wisniewski J.R., Schwanbeck R. High mobility group I/Y: multifunctional chromosomal proteins causally involved in tumor progression and malignant transformation (review). Int. J. Mol. Med. 2000, 6(4):409-419.
166. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
167. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
168. Lanahan A., et al. Growth factor-induced delayed early response genes. Mol. Cell. Biol. 1992, 12(9):3919-3929.
169. Chiappetta G., et al. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 1996, 13(11):2439-2446.
170. Lundberg K., et al. On the presence of the chromosomal proteins HMG I and HMG Y in rat organs. Biochim. Biophys. Acta 1989, 1009(3):277-279.
171. Weir H.M., et al. Structure of the HMG box motif in the B-domain of HMG1. EMBO J. 1993, 12(4):1311-1319.
172. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci. 2001, 26(3):167-174.
173. McCauley M.J., et al. HMGB binding to DNA: single and double box motifs. J. Mol. Biol. 2007, 374(4):993-1004.
174. Joshi S.R., et al. Nucleosome dynamics: HMGB1 relaxes canonical nucleosome structure to facilitate estrogen receptor binding. Nucleic Acids Res. 2012, 40(20):10161-10171.
175. Agresti A., Bianchi M.E. HMGB proteins and gene expression. Curr. Opin. Genet. Dev. 2003, 13(2):170-178.
176. Catena R., et al. HMGB4, a novel member of the HMGB family, is preferentially expressed in the mouse testis and localizes to the basal pole of elongating spermatids. Biol. Reprod. 2009, 80(2):358-366.
177. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell Biol. 1999, 19(8):5237-5246.
178. Calogero S., et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 1999, 22(3):276-280.
179. Dumitriu I.E., et al. HMGB1: guiding immunity from within. Trends Immunol. 2005, 26(7):381-387.
180. Bianchi M.E., Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 2007, 220:35-46.
181. Klune J.R., et al. HMGB1: endogenous danger signaling. Mol. Med. 2008, 14(7-8):476-484.
182. Ranzato E., et al. High mobility group box protein-1 in wound repair. Cells 2012, 1(4):699-710.
183. Hughes E.N., Engelsberg B.N., Billings P.C. Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2. J. Biol. Chem. 1992, 267(19):13520-13527.
184. Pil P.M., Lippard S.J. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 1992, 256(5054):234-237.
185. Zamble D.B., et al. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 1996, 35(31):10004-10013.
186. Lange S.S., Vasquez K.M. HMGB1: the jack-of-all-trades protein is a master DNA repair mechanic. Mol. Carcinog. 2009, 48(7):571-580.
187. Huang J.C., et al. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(22):10394-10398.
188. Trimmer E.E., et al. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities. Biochemistry 1998, 37(1):352-362.
189. Trimmer E.E., Essigmann J.M. Cisplatin. Essays Biochem. 1999, 34:191-211.
190. Jordan P., Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol. Life Sci. 2000, 57(8-9):1229-1235.
191. Wozniak K., Blasiak J. Recognition and repair of DNA-cisplatin adducts. Acta Biochim. Pol. 2002, 49(3):583-596.
192. Malina J., et al. Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts. Chem. Biol. 2002, 9(5):629-638.
193. Patrick S.M., Turchi J.J. Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro. Biochemistry 1998, 37(24):8808-8815.
194. Ugrinova I., et al. Native HMGB1 protein inhibits repair of cisplatin-damaged nucleosomes in vitro. Int. J. Biochem. Cell Biol. 2009, 41(7):1556-1562.
195. Ugrinova I., Pashev I.G., Pasheva E.A. Nucleosome binding properties and Co-remodeling activities of native and in vivo acetylated HMGB-1 and HMGB-2 proteins. Biochemistry 2009, 48(27):6502-6507.
196. Ugrinova I., Pashev I.G., Pasheva E.A. Post-synthetic acetylation of HMGB1 protein modulates its interactions with supercoiled DNA. Mol. Biol. Rep. 2009, 36(6):1399-1404.
197. Lange S.S., Reddy M.C., Vasquez K.M. Human HMGB1 directly facilitates interactions between nucleotide excision repair proteins on triplex-directed psoralen interstrand crosslinks. DNA Repair (Amst.) 2009, 8(7):865-872.
198. Reddy M.C., Christensen J., Vasquez K.M. Interplay between human high mobility group protein 1 and replication protein A on psoralen-cross-linked DNA. Biochemistry 2005, 44(11):4188-4195.
199. Lange S.S., Mitchell D.L., Vasquez K.M. High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(30):10320-10325.
200. Prasad R., et al. HMGB1 is a cofactor in mammalian base excision repair. Mol. Cell. 2007, 27(5):829-841.
201. Liu Y., Prasad R., Wilson S.H. HMGB1: roles in base excision repair and related function. Biochim. Biophys. Acta 2010, 1799(1-2):119-130.
202. Yumoto Y., et al. High mobility group proteins 1 and 2 can function as DNA-binding regulatory components for DNA-dependent protein kinase in vitro. J. Biochem. 1998, 124(3):519-527.
203. Stros M., Cherny D., Jovin T.M. HMG1 protein stimulates DNA end joining by promoting association of DNA molecules via their ends. Eur. J. Biochem. 2000, 267(13):4088-4097.
204. Yamanaka S., et al. Nucleosome linker proteins HMGB1 and histone H1 differentially enhance DNA ligation reactions. Biochem. Biophys. Res. Commun. 2002, 292(1):268-273.
205. Tonagawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
206. Hiom K., Gellert M. A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage. Cell 1997, 88(1):65-72.
207. Hiom K., Gellert M. Assembly of a 12/23 paired signal complex: a critical control point in V(D)J recombination. Mol. Cell. 1998, 1(7):1011-1019.
208. Mansilla-Soto J., Cortes P. VDJ recombination: Artemis and its in vivo role in hairpin opening. J. Exp. Med. 2003, 197(5):543-547.
209. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 2002, 71:101-132.
210. Sawchuk D.J., et al. V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA-bending proteins. J. Exp. Med. 1997, 185(11):2025-2032.
211. van Gent D.C., et al. Stimulation of V(D)J cleavage by high mobility group proteins. EMBO J. 1997, 16(10):2665-2670.
212. West R.B., Lieber M.R. The RAG-HMG1 complex enforces the 12/23 rule of V(D)J recombination specifically at the double-hairpin formation step. Mol. Cell Biol. 1998, 18(11):6408-6415.
213. Little A.J., et al. Cooperative recruitment of HMGB1 during V(D)J recombination through interactions with RAG1 and DNA. Nucleic Acids Res. 2013, 41(5):3289-3301.
214. Aidinis V., et al. The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2. Mol. Cell Biol. 1999, 19(10):6532-6542.
215. Ciubotaru M., et al. RAG and HMGB1 create a large bend in the 23RSS in the V(D)J recombination synaptic complexes. Nucleic Acids Res. 2013, 41(4):2437-2454.
216. Ciubotaru M., et al. The architecture of the 12RSS in V(D)J recombination signal and synaptic complexes. Nucleic Acids Res. 2015, 43(2):917-931.
217. Sawchuk D.J., et al. Ku70/Ku80 and DNA-dependent protein kinase catalytic subunit modulate RAG-mediated cleavage: implications for the enforcement of the 12/23 rule. J. Biol. Chem. 2004, 279(28):29821-29831.
218. Iyer R.R., et al. DNA mismatch repair: functions and mechanisms. Chem. Rev. 2006, 106(2):302-323.
219. Krynetski E.Y., et al. A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues. Cancer Res. 2003, 63(1):100-106.
220. Yuan F., et al. Evidence for involvement of HMGB1 protein in human DNA mismatch repair. J. Biol. Chem. 2004, 279(20):20935-20940.
221. Zhang Y., et al. Reconstitution of 5'-directed human mismatch repair in a purified system. Cell 2005, 122(5):693-705.
222. Hao Q., Cho W.C. Battle against cancer: an everlasting saga of p53. Int. J. Mol. Sci. 2014, 15(12):22109-22127.
223. Gupta A., et al. Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice. Radiat. Res. 2014, 181(1):1-8.
224. Speidel D. The role of DNA damage responses in p53 biology. Arch. Toxicol. 2015, 89(4):501-517.
225. Marcel V., Catez F., Diaz J.J. p53, a translational regulator: contribution to its tumour-suppressor activity. Oncogene 2015.
226. Menon V., Povirk L. Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ). Subcell Biochem. 2014, 85:321-336.
227. Hanawalt P.C., Ford J.M., Lloyd D.R. Functional characterization of global genomic DNA repair and its implications for cancer. Mutat. Res. 2003, 544(2-3):107-114.
228. Rubbi C.P., Milner J. p53-guardian of a genome's guardian?. Cell Cycle 2003, 2(1):20-21.
229. Sancar A., et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
230. Stros M., et al. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J. Biol. Chem. 2002, 277(9):7157-7164.
231. Vogelstein B., Kinzler K.W. p53 function and dysfunction. Cell 1992, 70(4):523-526.
232. Viadiu H., Fronza G., Inga A. Structural studies on mechanisms to activate mutant p53. Subcell Biochem. 2014, 85:119-132.
233. Motoyama N., Naka K. DNA damage tumor suppressor genes and genomic instability. Curr. Opin. Genet. Dev. 2004, 14(1):11-16.
234. Jayaraman L., et al. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev. 1998, 12(4):462-472.
235. Imamura T., et al. Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. J. Biol. Chem. 2001, 276(10):7534-7540.
236. McKinney K., Prives C. Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein. Mol. Cell Biol. 2002, 22(19):6797-6808.
237. Rowell J.P., et al. HMGB1-facilitated p53 DNA binding occurs via HMG-Box/p53 transactivation domain interaction, regulated by the acidic tail. Structure 2012, 20(12):2014-2024.
238. Livesey K.M., et al. Direct molecular interactions between HMGB1 and TP53 in colorectal cancer. Autophagy 2012, 8(5):846-848.
239. Livesey K.M., et al. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res. 2012, 72(8):1996-2005.